New Diabetes Options for Improved Outcomes - CHES378

New Diabetes Options for Improved Outcomes

by Susanne J. Pavlovich-Danis, MSN, ARNP-C, CDE, CRRN
CHES378
(4.3 / 25 ratings )

This course is credentialed for:
Health Education (1.00 CECH)

ONLINE
Price: $20.00
CE-PRO Price: $10.00

Summary:

Only 57% of people with diabetes have well-controlled blood glucose levels — defined by the American Diabetes Association as a three-month target blood glucose level (hemoglobin A1c) of less than 7% or defined by the American Association of Clinical Endocrinologists as less than 6.5%. For some people with diabetes, help may already be here in the form of the daily or weekly dosed glucagon-like-peptide-1 receptor agonists exenatide (Byetta, Bydureon), liraglutide (Victoza), dulaglutide (Trulicity), albiglutide (Tanzeum) and the amylin analog pramlintide acetate (Symlin). Many nurses and dietitians who work with patients with diabetes will have the responsibility of educating and monitoring patients who are using these important new treatments.

Objectives:

The goal of this program is to enhance nurses’ and dietitians’ ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to:
  • Describe the roles of amylin and the human incretin hormone glucagon-like-peptide-1 in regulating blood glucose levels
  • Explain three benefits of GLP-1 receptor agonists and amylin analog injection therapy
  • Discuss three nursing interventions to help patients adjust to and properly use GLP-1 receptor agonists or amylin analog therapy
 

 
Accreditation Information
 
This course is intended for multiple professions, including dietitians, health educators, and nurses.
 
Health educators: Take this version of the course to ensure you receive appropriate credit. 
 
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at lms.nurse.com and search for this topic title.
 
Sponsored by OnCourse Learning, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours.
 
Provider ID: CA0084 (98709) for 01/01/2012 to 12/31/2015, 114941 for 01/01/2016 to 12/31/2019.

Course Originally Released on: 10/10/2005
Date of Most Recent Review: 3/2/2015
Course Termination/Update Date: 3/2/2018

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

Sort By
CHRISTINE M - Norco, CA  ·  Feb 04, 2016
Could have been written a bit more professionally
Was this review helpful?  0
 
SUSAN K - Glendale, AZ  ·  Jan 02, 2015
too much detail to remember for each med
Was this review helpful?  0
 
Angela M - Carmel, IN  ·  Apr 12, 2013
It was great! Provided detailed information on this relatively new line of medications.
Was this review helpful?  0
 
Joan M - Memphis, TN  ·  Oct 08, 2012
I was interested to learn the origin of this new type of diabetes medication, its effects, side-effects, and safety.
Was this review helpful?  0
 
Kristen P - beltsville, MD  ·  Sep 27, 2012
Overall, a very informative course. Learned some new information which makes these coursesIP
Was this review helpful?  0
 
ONLINE
Price: $20.00
CE-PRO Price: $10.00